Search

everythinglearnresearchcommunity

for

Search:↓

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Dr. Marina Kovalevsky and her daughter were hospitalized for suspected politically motivated thallium poisoning in Moscow.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A patient's grey hair regained color during treatment with adalimumab.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Ocrelizumab may cause pancreatitis in some patients.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

BMS-470539 reduces skin fibrosis and inflammation.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

TOF-SIMS improved chemical mapping in cells, confirming gunshot residue, tracking anti-tumor drugs, and identifying molecules in mosquitoes and wounds.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

Booster doses of Covaxin improve protection against the Omicron variant.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Microbeam radiation therapy's dose distribution changes with depth.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.